| Report Title | Price | Action |
|---|---|---|
| Muscle Spasm (Musculoskeletal) - Drugs in Development, 2021
Muscle Spasm (Musculoskeletal) - Drugs in Development, 2021 Summary Muscle Spasm (Musculoskeletal) - Drugs in Development, 2021 provides an overview...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Acute Sensorineural Hearing Loss (Ear Nose Throat Disorders) - Drugs in Development, 2021
Acute Sensorineural Hearing Loss (Ear Nose Throat Disorders) - Drugs in Development, 2021 Summary Acute Sensorineural Hearing Loss (Ear Nose Throat ...
Published: Apr-2021 | No. of Pages: 45
|
$ 2000 | |
| Atrial Natriuretic Peptide Receptor 2 (Atrial Natriuretic Peptide Receptor Type B or Guanylate Cyclase B or NPR2 or EC 4.6.1.2) - Drugs in Development, 2021
Atrial Natriuretic Peptide Receptor 2 (Atrial Natriuretic Peptide Receptor Type B or Guanylate Cyclase B or NPR2 or EC 4.6.1.2) - Drugs in Development...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Cyclin Dependent Kinase (CDK or EC 2.7.11.22) - Drugs in Development, 2021
Cyclin Dependent Kinase (CDK or EC 2.7.11.22) - Drugs in Development, 2021 Summary Cyclin Dependent Kinase (CDK or EC 2.7.11.22) - Drugs in Developm...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Zinc Finger Protein GLI1 (Glioma Associated Oncogene or Oncogene GLI or GLI1) - Drugs in Development, 2021
Zinc Finger Protein GLI1 (Glioma Associated Oncogene or Oncogene GLI or GLI1) - Drugs in Development, 2021 Summary Zinc Finger Protein GLI1 (Glioma ...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Bacteremia (Infectious Disease) - Drugs in Development, 2021
Bacteremia (Infectious Disease) - Drugs in Development, 2021 Summary Bacteremia (Infectious Disease) - Drugs in Development, 2021 provides an overvi...
Published: Apr-2021 | No. of Pages: 45
|
$ 2000 | |
| Wet (Neovascular / Exudative) Macular Degeneration (Ophthalmology) - Drugs in Development, 2021
Wet (Neovascular / Exudative) Macular Degeneration (Ophthalmology) - Drugs in Development, 2021 Summary Wet (Neovascular / Exudative) Macular Degene...
Published: Apr-2021 | No. of Pages: 300
|
$ 2500 | |
| Muscle Spasticity (Central Nervous System) - Drugs in Development, 2021
Muscle Spasticity (Central Nervous System) - Drugs in Development, 2021 Summary Muscle Spasticity (Central Nervous System) - Drugs in Development, 2...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 | |
| Acute Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021
Acute Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021 Summary Acute Spinal Cord Injury (Central Nervous System) - Drugs in ...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| C-C Chemokine Receptor Type 2 (Monocyte Chemoattractant Protein 1 Receptor or CD192 or CCR2) - Drugs in Development, 2021
C-C Chemokine Receptor Type 2 (Monocyte Chemoattractant Protein 1 Receptor or CD192 or CCR2) - Drugs in Development, 2021 Summary C-C Chemokine Rece...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Ectonucleoside Triphosphate Diphosphohydrolase 1 (NTPDase 1 or Ecto ATP Diphosphohydrolase 1 or Ecto Apyrase or Lymphoid Cell Activation Antigen or CD39 or ENTPD1 or EC 3.6.1.5) - Drugs in Development, 2021
Ectonucleoside Triphosphate Diphosphohydrolase 1 (NTPDase 1 or Ecto ATP Diphosphohydrolase 1 or Ecto Apyrase or Lymphoid Cell Activation Antigen or CD...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| 50S Ribosomal Subunit (50S RNA) - Drugs in Development, 2021
50S Ribosomal Subunit (50S RNA) - Drugs in Development, 2021 Summary 50S Ribosomal Subunit (50S RNA) - Drugs in Development, 2021 provides in depth ...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Dedifferentiated Liposarcoma (Oncology) - Drugs in Development, 2021
Dedifferentiated Liposarcoma (Oncology) - Drugs in Development, 2021 Summary Dedifferentiated Liposarcoma (Oncology) - Drugs in Development, 2021 pr...
Published: Apr-2021 | No. of Pages: 45
|
$ 2000 | |
| Xerostomia (Mouth And Dental Disorders) - Drugs in Development, 2021
Xerostomia (Mouth And Dental Disorders) - Drugs in Development, 2021 Summary Xerostomia (Mouth And Dental Disorders) - Drugs in Development, 2021 pr...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Mycobacterium Tuberculosis Infections (Infectious Disease) - Drugs in Development, 2021
Mycobacterium Tuberculosis Infections (Infectious Disease) - Drugs in Development, 2021 Summary Mycobacterium Tuberculosis Infections (Infectious Di...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
| Adenocarcinoma Of The Gastroesophageal Junction (Oncology) - Drugs in Development, 2021
Adenocarcinoma Of The Gastroesophageal Junction (Oncology) - Drugs in Development, 2021 Summary Adenocarcinoma Of The Gastroesophageal Junction (Onc...
Published: Apr-2021 | No. of Pages: 260
|
$ 2500 | |
| Casein Kinase 2 (CSNK2 or EC 2.7.11.1) - Drugs in Development, 2021
Casein Kinase 2 (CSNK2 or EC 2.7.11.1) - Drugs in Development, 2021 Summary Casein Kinase 2 (CSNK2 or EC 2.7.11.1) - Drugs in Development, 2021 prov...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Endothelin B Receptor (Endothelin Receptor Non Selective Type or EDNRB) - Drugs in Development, 2021
Endothelin B Receptor (Endothelin Receptor Non Selective Type or EDNRB) - Drugs in Development, 2021 Summary Endothelin B Receptor (Endothelin Recep...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Acetyl CoA Carboxylase 2 (ACC2 or ACC Beta or ACACB or EC 6.4.1.2 or EC 6.3.4.14) - Drugs in Development, 2021
Acetyl CoA Carboxylase 2 (ACC2 or ACC Beta or ACACB or EC 6.4.1.2 or EC 6.3.4.14) - Drugs in Development, 2021 Summary Acetyl CoA Carboxylase 2 (ACC...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Malignant Neoplasms (Oncology) - Drugs in Development, 2021
Malignant Neoplasms (Oncology) - Drugs in Development, 2021 Summary Malignant Neoplasms (Oncology) - Drugs in Development, 2021 provides an overview...
Published: Apr-2021 | No. of Pages: 45
|
$ 2000 |